|
发表于 2022-11-22 20:51:20
|
显示全部楼层
Abstract GS1 04 IMpassion130 Efficacy in immune biomarker subgroups from the global, randomized, double blind, placebo controlled, phase III study of atezolizumab nab paclitaxel in patients with treatment naГЇve, locally advanced or metastatic triple negative breast cancer <a href=http://stromectol.ink/>stromectol purchase</a> |
|